The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discovery of a functional biomarker for sensitivity to poly ADP ribose polymerase inhibitors (PARPi) in colorectal cancer (CRC).
 
Sebastian Meltzer
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BMS Norway (Inst); Illumina (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
 
Peter Eide
Employment - Oncosyne AS
Leadership - Oncosyne AS
Stock and Other Ownership Interests - Oncosyne AS
Consulting or Advisory Role - Isofol Medical (Inst)
Research Funding - Isofol Medical (Inst)
Patents, Royalties, Other Intellectual Property - Oncosyne AS (Inst)
 
Torben Lüders
No Relationships to Disclose
 
Diana Bordin
No Relationships to Disclose
 
Andliena Tahiri
No Relationships to Disclose
 
Shixiong Wang
No Relationships to Disclose
 
Paula Bousquet
No Relationships to Disclose
 
Anniken Fuglestad
No Relationships to Disclose
 
Knut M. Augestad
No Relationships to Disclose
 
Christer Andreassen
Employment - Oncosyne AS
 
Teijo Pellinen
No Relationships to Disclose
 
Anne Ree
No Relationships to Disclose
 
Jarle Bruun
Employment - Oncosyne AS
Leadership - Oncosyne AS
Stock and Other Ownership Interests - Oncosyne AS
Consulting or Advisory Role - Isofol Medical (Inst)
Research Funding - Isofol Medical (Inst)
Patents, Royalties, Other Intellectual Property - Oncosyne AS (Inst)